Combining Ketamine and Deep TMS: A New Frontier in Treating Depression
Emerging evidence suggests that combining these interventions may enhance treatment outcomes and provide options for patients who have not responded to traditional therapies.
The High Price of Treatment Resistant Depression for Employers
Workforce mental health isn't just an HR issue, it's also a business imperative. Companies that integrate evidence-based solutions into their benefits reduce medical costs, improve productivity, and retain top talent.
presented by
RCM Outsourcing: Balancing Human Expertise & Smart Technology
Greenway Health blends smart technology with human expertise to elevate revenue cycle.
Mental Health Startup Combining Psychiatry with Novel Treatments Launches with $5.4M in Funding
Being Health, a startup that launched last week, offers a care team that includes psychiatrists, psychotherapists, nurse anesthetists, functional medicine physicians, nutritionists, acupuncturists and care advocates. It serves patients both virtually and in person.
Should Employers and Insurers Cover Psychedelic-Assisted Therapy?
Despite ketamine-assisted therapy being approved for treating several mental health conditions, it's generally not covered by insurance or employers. Though that likely won't always be the case, as psychedelics gather more research and employers notice the benefits for their workplaces.
How One Company Is Making Psychedelic Therapy a Workplace Benefit
Enthea, a benefit plan administrator, works with self-insured employers to provide insurance coverage for psychedelic-assisted therapy. The company has gained $2 million in seed funding, led by Tabula Rasa Ventures. With the money, it is planning a nationwide rollout.
FDA approves J&J’s Spravato as first novel antidepressant in decades
The drug, a reformulation of ketamine, was approved for patients who have failed on other antidepressants. The original form of ketamine, approved as an anesthetic, has long been explored as a treatment for depression.
NEMT Partner Guide: Why Payers and Providers Should Choose MediDrive’s TMS
Alan Murray on improving access for medical transportation.
Special K: When street drugs treat depression
The hallucinogenic drug ketamine, or Special K as it’s known on the street, has been used as an anesthetic for decades. Now, it’s being used to treat severe cases of depression – but there are some critics. Unlike other depression drugs like Prozac or Lexapro, ketamine is said to relieve symptoms in hours, not weeks. […]